Bausch Health Co. Inc. (BHC) Announces Board Changes

Bausch Health Companies Inc. (NYSE: BHC) today announced that Richard De Schutter and Dr. Argeris Karabelas are retiring from the Company's Board of Directors, effective as of the upcoming 2023 annual meeting of shareholders of the Company. Following the retirements of Mr. De Schutter and Dr. Karabelas, the size of the Board will be reduced to 10 directors.

"Dick and Jerry have been valued members of our Board and their service to the Company has been greatly appreciated. The Company and entire Board are grateful for their contributions," said John A. Paulson, Chairperson of the Bausch Health Board.

As result of the retirements of Mr. De Schutter and Dr. Karabelas, the Board has refreshed certain Board Committees. The current Board Committee structure is available on the Company's website: https://ir.bauschhealth.com/corporate-governance.

You May Also Be Interested In

• Editas Medicine adds cardiovascular geneticist to its board
• Marriott Vacations Worldwide names new strategy and transformation chief
• Nextech3D.ai partners with F2B Services for LED and AI software sales